Skip to main content

cholestyramine

Generic: CHOLESTYRAMINE·Brand: CHOLESTYRAMINE, CHOLESTYRAMINE LIGHT, CHOLYBAR, LOCHOLEST, LOCHOLEST LIGHT, PREVALITE, QUESTRAN, QUESTRAN LIGHT

cholestyramine: 2 clinical trials tracked.

cholestyramine evidence translation

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about cholestyramine, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors

Related indications

Multiple Sclerosis
Clinical Trial Registry Records (2)

Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants With Relapsing Forms of Multiple Sclerosis

NCT06141473Registry updated 2026-07-20·Phase 3·SNY
Active, not recruiting

Primary endpoint: Annualized relapse rate (ARR) during the study period assessed by protocol defined adjudicated relapses

InterventionalRandomizedquadruple1,655 enrolledStarted 2023-12Completion 2027-0550 sites · United StatesSanofi

Pilot Trial of Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies

NCT05443425Registry updated 2026-07-08·Phase 1
Recruiting

Primary endpoint: Incidence of adverse events

Interventionalopen18 targetStarted 2023-06Completion 2027-011 site · United StatesCity of Hope Medical Center